 | • レポートコード：D005-05192 • 出版社/出版日：GlobalInfoResearch / 2020年5月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ジペプチジルペプチダーゼ-4（DPP-4）阻害剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。ジペプチジルペプチダーゼ-4（DPP-4）阻害剤の種類別市場規模（ネシーナ、トラジェンタ、オングリザ、ジャヌビア、その他）、用途別市場規模（2型糖尿病、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Sanofi、AstraZeneca、Merck、Takeda、Pfizer、Eli Lilly、Boehringer Ingelheim、Bristol-Myers Squibb、Novo Nordisk、GlaxoSmithKline ・地域別グローバル市場分析 2015年-2020年 ・ジペプチジルペプチダーゼ-4（DPP-4）阻害剤の北米市場（アメリカ、カナダ、メキシコ） ・ジペプチジルペプチダーゼ-4（DPP-4）阻害剤のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ジペプチジルペプチダーゼ-4（DPP-4）阻害剤のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ジペプチジルペプチダーゼ-4（DPP-4）阻害剤の南米市場（ブラジル、アルゼンチン） ・ジペプチジルペプチダーゼ-4（DPP-4）阻害剤の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ネシーナ、トラジェンタ、オングリザ、ジャヌビア、その他 ・用途別分析：2型糖尿病、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.2% in the forecast period of 2020 to 2025 and will expected to reach USD 10140 million by 2025, from USD 9302.2 million in 2019.
The Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market has been segmented into
Nesina
Tradjenta
Onglyza
Januvia
Others
By Application, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors has been segmented into:
Type 2 Diabetes
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market presented in the report. This section sheds light on the sales growth of different regional and country-level Dipeptidyl Peptidase-4 (DPP-4) Inhibitors markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market.
The report offers in-depth assessment of the growth and other aspects of the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Share Analysis
Dipeptidyl Peptidase-4 (DPP-4) Inhibitors competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors sales, revenue and market share for each player covered in this report.
The major players covered in Dipeptidyl Peptidase-4 (DPP-4) Inhibitors are:
Sanofi
AstraZeneca
Merck
Takeda
Pfizer
Eli Lilly
Boehringer Ingelheim
Bristol-Myers Squibb
Novo Nordisk
GlaxoSmithKline
Among other players domestic and global, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, with price, sales, revenue and global market share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in 2018 and 2019.
Chapter 3, the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Nesina
1.2.3 Tradjenta
1.2.4 Onglyza
1.2.5 Januvia
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Type 2 Diabetes
1.3.3 Others
1.4 Overview of Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market
1.4.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sanofi SWOT Analysis
2.1.4 Sanofi Product and Services
2.1.5 Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 AstraZeneca SWOT Analysis
2.2.4 AstraZeneca Product and Services
2.2.5 AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Takeda
2.4.1 Takeda Details
2.4.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Takeda SWOT Analysis
2.4.4 Takeda Product and Services
2.4.5 Takeda Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Pfizer SWOT Analysis
2.5.4 Pfizer Product and Services
2.5.5 Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Eli Lilly SWOT Analysis
2.6.4 Eli Lilly Product and Services
2.6.5 Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Boehringer Ingelheim
2.7.1 Boehringer Ingelheim Details
2.7.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Boehringer Ingelheim SWOT Analysis
2.7.4 Boehringer Ingelheim Product and Services
2.7.5 Boehringer Ingelheim Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bristol-Myers Squibb
2.8.1 Bristol-Myers Squibb Details
2.8.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bristol-Myers Squibb SWOT Analysis
2.8.4 Bristol-Myers Squibb Product and Services
2.8.5 Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Novo Nordisk
2.9.1 Novo Nordisk Details
2.9.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Novo Nordisk SWOT Analysis
2.9.4 Novo Nordisk Product and Services
2.9.5 Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 GlaxoSmithKline
2.10.1 GlaxoSmithKline Details
2.10.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 GlaxoSmithKline SWOT Analysis
2.10.4 GlaxoSmithKline Product and Services
2.10.5 GlaxoSmithKline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturer Market Share in 2019
3.3.2 Top 6 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Market Share by Regions
4.1.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Market Share by Regions (2015-2020)
4.1.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Market Share by Regions (2015-2020)
4.2 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020)
4.3 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020)
4.5 South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Market Share by Country
5.1.1 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Market Share by Country (2015-2020)
5.1.2 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Market Share by Country (2015-2020)
5.2 United States Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020)
5.3 Canada Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020)
5.4 Mexico Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Market Share by Country
6.1.1 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Market Share by Country (2015-2020)
6.1.2 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Market Share by Country (2015-2020)
6.2 Germany Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020)
6.3 UK Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020)
6.4 France Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020)
6.5 Russia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020)
6.6 Italy Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Market Share by Regions (2015-2020)
7.2 China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020)
7.3 Japan Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020)
7.4 Korea Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020)
7.5 India Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020)
7.7 Australia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Market Share by Country
8.1.1 South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Market Share by Country (2015-2020)
8.1.2 South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Market Share by Country (2015-2020)
8.2 Brazil Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020)
8.3 Argentina Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020)
9.3 Turkey Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020)
9.4 Egypt Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020)
9.5 South Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Market Share by Type (2015-2020)
10.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Market Share by Type (2015-2020)
10.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Type (2015-2020)
11 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Segment by Application
11.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application (2015-2020)
11.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Application (2015-2020)
11.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Application (2015-2020)
12 Market Forecast
12.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Growth Rate (2021-2025)
12.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Forecast by Regions (2021-2025)
12.2.1 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Forecast (2021-2025)
12.2.2 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Forecast (2021-2025)
12.2.3 Asia-Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Forecast (2021-2025)
12.2.4 South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Forecast (2021-2025)
12.2.5 Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Forecast (2021-2025)
12.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Forecast by Type (2021-2025)
12.3.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Forecast by Type (2021-2025)
12.3.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Share Forecast by Type (2021-2025)
12.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Forecast by Application (2021-2025)
12.4.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Forecast by Application (2021-2025)
12.4.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Sanofi Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Major Business
Table 9. Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Total Revenue (USD Million) (2017-2018)
Table 10. Sanofi SWOT Analysis
Table 11. Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product and Services
Table 12. Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 14. AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Major Business
Table 15. AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Total Revenue (USD Million) (2017-2018)
Table 16. AstraZeneca SWOT Analysis
Table 17. AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product and Services
Table 18. AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Merck Basic Information, Manufacturing Base and Competitors
Table 20. Merck Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Major Business
Table 21. Merck Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Total Revenue (USD Million) (2017-2018)
Table 22. Merck SWOT Analysis
Table 23. Merck Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product and Services
Table 24. Merck Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Takeda Basic Information, Manufacturing Base and Competitors
Table 26. Takeda Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Major Business
Table 27. Takeda Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Total Revenue (USD Million) (2017-2018)
Table 28. Takeda SWOT Analysis
Table 29. Takeda Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product and Services
Table 30. Takeda Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Pfizer Basic Information, Manufacturing Base and Competitors
Table 32. Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Major Business
Table 33. Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Total Revenue (USD Million) (2017-2018)
Table 34. Pfizer SWOT Analysis
Table 35. Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product and Services
Table 36. Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 38. Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Major Business
Table 39. Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Total Revenue (USD Million) (2017-2018)
Table 40. Eli Lilly SWOT Analysis
Table 41. Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product and Services
Table 42. Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 44. Boehringer Ingelheim Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Major Business
Table 45. Boehringer Ingelheim Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Total Revenue (USD Million) (2017-2018)
Table 46. Boehringer Ingelheim SWOT Analysis
Table 47. Boehringer Ingelheim Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product and Services
Table 48. Boehringer Ingelheim Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 50. Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Major Business
Table 51. Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Total Revenue (USD Million) (2017-2018)
Table 52. Bristol-Myers Squibb SWOT Analysis
Table 53. Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product and Services
Table 54. Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 56. Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Major Business
Table 57. Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Total Revenue (USD Million) (2017-2018)
Table 58. Novo Nordisk SWOT Analysis
Table 59. Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product and Services
Table 60. Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 62. GlaxoSmithKline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Major Business
Table 63. GlaxoSmithKline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Total Revenue (USD Million) (2017-2018)
Table 64. GlaxoSmithKline SWOT Analysis
Table 65. GlaxoSmithKline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product and Services
Table 66. GlaxoSmithKline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Manufacturer (2018-2019) (K MT)
Table 68. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Regions (2015-2020) (K MT)
Table 70. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Regions (2015-2020)
Table 71. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Countries (2015-2020) (K MT)
Table 73. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Countries (2015-2020)
Table 74. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Countries (2015-2020)
Table 76. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Countries (2015-2020) (K MT)
Table 77. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Countries (2015-2020)
Table 78. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Regions (2015-2020) (K MT)
Table 80. Asia-Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Countries (2015-2020) (K MT)
Table 83. South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Countries (2015-2020)
Table 84. South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Countries (2015-2020) (K MT)
Table 87. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Countries (2015-2020)
Table 90. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2015-2020) (K MT)
Table 91. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Share by Type (2015-2020)
Table 92. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2015-2020) (USD Million)
Table 93. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Type (2015-2020)
Table 94. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2015-2020) (K MT)
Table 95. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Share by Application (2015-2020)
Table 96. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Forecast by Regions (2021-2025) (K MT)
Table 97. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Share Forecast by Regions (2021-2025)
Table 98. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Forecast by Type (2021-2025) (K MT)
Table 99. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Share Forecast by Type (2021-2025)
Table 100. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Forecast by Application (2021-2025)
Table 101. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Picture
Figure 2. Global Sales Market Share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Type in 2019
Figure 3. Nesina Picture
Figure 4. Tradjenta Picture
Figure 5. Onglyza Picture
Figure 6. Januvia Picture
Figure 7. Others Picture
Figure 8. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application in 2018
Figure 9. Type 2 Diabetes Picture
Figure 10. Others Picture
Figure 11. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Manufacturer in 2019
Figure 32. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 37. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Regions (2015-2020)
Figure 39. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Regions in 2018
Figure 40. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020)
Figure 41. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020)
Figure 43. South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020)
Figure 45. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Countries (2015-2020)
Figure 47. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Countries in 2018
Figure 48. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Countries in 2018
Figure 50. United States Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 51. Canada Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Mexico Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 53. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Countries in 2019
Figure 56. Germany Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 57. UK Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 58. France Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Russia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Italy Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 61. Asia-Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Regions 2019
Figure 64. China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 65. Japan Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Korea Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 67. India Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 68. Southeast Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 69. South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Countries in 2019
Figure 71. South America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Countries in 2019
Figure 72. Brazil Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 73. Argentina Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 74. Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 79. Egypt Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 80. Turkey Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 81. South Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2015-2020) (K MT)
Figure 82. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2021-2025) (K MT)
Figure 83. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Forecast (2021-2025) (K MT)
Figure 85. Europe Sales Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Forecast (2021-2025) (K MT)
Figure 86. Asia-Pacific Sales Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Forecast (2021-2025) (K MT)
Figure 87. South America Sales Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Forecast (2021-2025) (K MT)
Figure 88. Middle East & Africa Sales Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Forecast (2021-2025) (K MT)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
ジペプチジルペプチダーゼIV（DPP-IV）阻害剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The D…- mTOR阻害剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global mTOR Inhibitors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The mTOR Inhibitors market report…
- 酵素阻害剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Enzyme Inhibitors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 0.8% in the forecast period of 2020 to 2025 and will expected to reach USD 152460 million by 2025, from USD 147910 million in 2019. The Enzyme Inhibitors …
- 移行阻害剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Migration Inhibitors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Migration Inhibitors mar…
- インターロイキン阻害剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Interleukin Inhibitors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 13.3% in the forecast period of 2020 to 2025 and will expected to reach USD 28060 million by 2025, from USD 17020 million in 2019. The Interleukin In…